{"id":6731,"date":"2025-03-26T08:06:25","date_gmt":"2025-03-26T12:06:25","guid":{"rendered":"https:\/\/dewpointx.com\/?p=6731"},"modified":"2025-03-26T08:26:40","modified_gmt":"2025-03-26T12:26:40","slug":"dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025","status":"publish","type":"post","link":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/","title":{"rendered":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>Dewpoint will present two posters at AACR&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Condensate modulators (c-mods) demonstrate robust anti-tumor effects across multiple types of cancer&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>C-mods modulate the oncogenic function of historically undruggable targets MYC and beta catenin&nbsp;&nbsp;<\/li>\n<\/ul>\n\n\n\n<p><strong>Boston, Massachusetts, March 26, 2025<\/strong> \u2013 Dewpoint Therapeutics Inc. \u2013 the leading biotechnology company in <a href=\"https:\/\/youtu.be\/qkDM9gPpC1A\">transforming condensate biology into medicine<\/a>, announced today the publication of two abstracts accepted for presentation at the American Association of Cancer Research (AACR) Annual Meeting, taking place in Chicago, IL, between April 25-30, 2025.<\/p>\n\n\n\n<p>\u201cWe are excited to share promising results from our oncology pipeline, that demonstrate profound pre-clinical effects produced by condensate modulating compounds (c-mods). These c-mods alter the oncogenic functions of the \u2018holy grail\u2019 targets MYC and beta catenin through novel mechanisms of action that leverage our unique expertise in condensate biology\u201d, said Dr. Ameet Nathwani, Dewpoint\u2019s Chief Executive Officer.<\/p>\n\n\n\n<p>Dewpoint will present the following two posters:&nbsp;<\/p>\n\n\n\n<div class=\"wp-block-group is-vertical is-content-justification-left is-layout-flex wp-container-core-group-is-layout-c0ca7d81 wp-block-group-is-layout-flex\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:100%\">\n<figure class=\"wp-block-table has-medium-font-size wp-container-content-9cfa9a5a\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Title<\/strong>&nbsp;<\/td><td>Beta catenin c-mods are orally bioavailable small-molecules targeting Wnt-driven tumors&nbsp;<\/td><\/tr><tr><td><strong>Abstract<\/strong>&nbsp;<\/td><td>#1751; see abstract on the <a href=\"https:\/\/www.abstractsonline.com\/pp8\/#!\/20273\/presentation\/5831\">AACR page<\/a><\/td><\/tr><tr><td><strong>Presented by<\/strong>&nbsp;<\/td><td>Isaac Klein, M.D.\/Ph.D.<\/td><\/tr><tr><td><strong>Date &amp; time<\/strong>&nbsp;<\/td><td>April 28, 2025 | 9:00 AM \u2013 12:00 PM CST&nbsp;&nbsp;<\/td><\/tr><tr><td><strong>Session<\/strong>&nbsp;<\/td><td>Experimental and Molecular Therapeutics | Novel Antitumor Agents 1&nbsp;<\/td><\/tr><tr><td><strong>Location<\/strong>&nbsp;<\/td><td>Poster Section 22 | Poster Board #3&nbsp;<\/td><\/tr><tr><td><strong><\/strong>&nbsp;<\/td><td>&nbsp;<\/td><\/tr><tr><td><strong>Title<\/strong>&nbsp;<\/td><td>MYC condensate-modulating small molecules demonstrate robust antitumor activity in animal models of ovarian cancer and other solid tumors&nbsp;<\/td><\/tr><tr><td><strong>Abstract<\/strong>&nbsp;<\/td><td>#6987; see abstract on the <a href=\"https:\/\/www.abstractsonline.com\/pp8\/#!\/20273\/presentation\/3934\">AACR page<\/a><\/td><\/tr><tr><td><strong>Presented by<\/strong>&nbsp;<\/td><td>Ann Boija, Ph.D.&nbsp;<\/td><\/tr><tr><td><strong>Date &amp; time<\/strong>&nbsp;<\/td><td>Apr 30, 2025 | 9:00 AM \u2013 12:00 PM CST&nbsp;<\/td><\/tr><tr><td><strong>Session<\/strong>&nbsp;<\/td><td>Chemistry | Lead Identification and Optimization&nbsp;<\/td><\/tr><tr><td><strong>Location<\/strong>&nbsp;<\/td><td>Poster Section 25 | Poster Board #16&nbsp;<\/td><\/tr><\/tbody><\/table><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p><strong>About Dewpoint Therapeutics\u202f\u202f<\/strong>&nbsp;<\/p>\n\n\n\n<p>Dewpoint is the leading biotech company in the application of biomolecular condensate biology towards the development of a new generation of therapeutics to address diseases of high unmet need. The realization that a vast range of conditions are regulated by or arise from the dysfunction of condensates has provided new possibilities for modulating the function of high-value targets previously deemed \u2018undruggable,\u2019 opening unexplored avenues to identify hundreds of novel therapeutic targets. Dewpoint\u2019s proprietary AI\/ML-powered state-of-the-art platform underlies a drug discovery pipeline that spans multiple therapeutic areas, including oncology, neurodegenerative, cardiopulmonary, and metabolic diseases. Through collaborations with Bayer, Novo Nordisk, Evotec, and Mitsubishi Tanabe Pharma Corporation, Dewpoint pushes the boundaries to accelerate the translation of condensate biology into medicine for patients suffering from difficult-to-treat diseases. Learn more at\u202f<a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fdewpointx.com%2F&amp;data=05%7C02%7CJeff%40concertai.com%7C8da94ed73d9347e33e6608dd12dd0b56%7C61a32d1a5fde47799b503fc4a615ddc4%7C1%7C0%7C638687462784930685%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=aVnuUEqDJH4nLhaODL0cDuyhAUfLC9oKTO4IYtItFCM%3D&amp;reserved=0\" target=\"_blank\" rel=\"noreferrer noopener\">Dewpointx.com<\/a>\u202fand follow us on\u202f\u202f<a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fdewpointtherapeutics%2F&amp;data=05%7C02%7CJeff%40concertai.com%7C8da94ed73d9347e33e6608dd12dd0b56%7C61a32d1a5fde47799b503fc4a615ddc4%7C1%7C0%7C638687462784959736%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=sxpXQqE8tYnaG05%2BTSidypO%2BQSbpG3%2BWAuPbdCri4uA%3D&amp;reserved=0\" target=\"_blank\" rel=\"noreferrer noopener\">LinkedIn<\/a>.&nbsp;<\/p>\n\n\n\n<p><strong>About Condensates\u202f\u202f<\/strong>&nbsp;<br>Condensates are membraneless organelles that form dynamically throughout the cell via a process called phase separation. These subcellular compartments organize and concentrate molecules within cells to enable a diversity of key biochemical processes. The dysregulation of biomolecular condensates has been observed in many diseases, including cancer, diabetes, cardiopulmonary and neurological disorders. Condensate-modulating drugs (c-mods) potentially provide novel therapeutic options for complex diseases and historically undruggable targets. Learn more about condensate science at\u202f<a href=\"https:\/\/nam12.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fcondensates.com%2F&amp;data=05%7C02%7CJeff%40concertai.com%7C8da94ed73d9347e33e6608dd12dd0b56%7C61a32d1a5fde47799b503fc4a615ddc4%7C1%7C0%7C638687462784910186%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=57gj0Y6NMcTunVu2HSOXbUuS%2F5JER%2FCVH4Ff6lQRGKU%3D&amp;reserved=0\" target=\"_blank\" rel=\"noreferrer noopener\">Condensates.com<\/a>.<strong>\u202f<\/strong>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, Massachusetts, March 26, 2025 \u2013 Dewpoint Therapeutics Inc. \u2013 the leading biotechnology company in transforming condensate biology into medicine, [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":3339,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[5],"tags":[48],"class_list":["post-6731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-releases","tag-add-to-home-page"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Boston, Massachusetts, March 26, 2025 \u2013 Dewpoint Therapeutics Inc. \u2013 the leading biotechnology company in transforming condensate biology into medicine, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Dewpoint Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-26T12:06:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-26T12:26:40+00:00\" \/>\n<meta name=\"author\" content=\"Jennifer Tallman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@dewpoint_tx\" \/>\n<meta name=\"twitter:site\" content=\"@dewpoint_tx\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jennifer Tallman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\"},\"author\":{\"name\":\"Jennifer Tallman\",\"@id\":\"https:\/\/dewpointx.com\/#\/schema\/person\/1c488cd606671d5d3392602755639a0c\"},\"headline\":\"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0\",\"datePublished\":\"2025-03-26T12:06:25+00:00\",\"dateModified\":\"2025-03-26T12:26:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\"},\"wordCount\":493,\"publisher\":{\"@id\":\"https:\/\/dewpointx.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png\",\"keywords\":[\"Add to home page\"],\"articleSection\":[\"Press releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\",\"url\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\",\"name\":\"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/dewpointx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png\",\"datePublished\":\"2025-03-26T12:06:25+00:00\",\"dateModified\":\"2025-03-26T12:26:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage\",\"url\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png\",\"contentUrl\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png\",\"width\":1000,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dewpointx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dewpointx.com\/#website\",\"url\":\"https:\/\/dewpointx.com\/\",\"name\":\"Dewpoint Therapeutics\",\"description\":\"The Biomolecular Condensates Company\",\"publisher\":{\"@id\":\"https:\/\/dewpointx.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dewpointx.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dewpointx.com\/#organization\",\"name\":\"Dewpoint Therapeutics\",\"url\":\"https:\/\/dewpointx.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dewpointx.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2022\/11\/favicon.png\",\"contentUrl\":\"https:\/\/dewpointx.com\/wp-content\/uploads\/2022\/11\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Dewpoint Therapeutics\"},\"image\":{\"@id\":\"https:\/\/dewpointx.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/dewpoint_tx\",\"https:\/\/www.linkedin.com\/company\/dewpointtherapeutics\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/dewpointx.com\/#\/schema\/person\/1c488cd606671d5d3392602755639a0c\",\"name\":\"Jennifer Tallman\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/","og_locale":"en_US","og_type":"article","og_title":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics","og_description":"Boston, Massachusetts, March 26, 2025 \u2013 Dewpoint Therapeutics Inc. \u2013 the leading biotechnology company in transforming condensate biology into medicine, [&hellip;]","og_url":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/","og_site_name":"Dewpoint Therapeutics","article_published_time":"2025-03-26T12:06:25+00:00","article_modified_time":"2025-03-26T12:26:40+00:00","author":"Jennifer Tallman","twitter_card":"summary_large_image","twitter_creator":"@dewpoint_tx","twitter_site":"@dewpoint_tx","twitter_misc":{"Written by":"Jennifer Tallman","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#article","isPartOf":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/"},"author":{"name":"Jennifer Tallman","@id":"https:\/\/dewpointx.com\/#\/schema\/person\/1c488cd606671d5d3392602755639a0c"},"headline":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0","datePublished":"2025-03-26T12:06:25+00:00","dateModified":"2025-03-26T12:26:40+00:00","mainEntityOfPage":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/"},"wordCount":493,"publisher":{"@id":"https:\/\/dewpointx.com\/#organization"},"image":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png","keywords":["Add to home page"],"articleSection":["Press releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/","url":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/","name":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0 | Dewpoint Therapeutics","isPartOf":{"@id":"https:\/\/dewpointx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage"},"image":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png","datePublished":"2025-03-26T12:06:25+00:00","dateModified":"2025-03-26T12:26:40+00:00","breadcrumb":{"@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#primaryimage","url":"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png","contentUrl":"https:\/\/dewpointx.com\/wp-content\/uploads\/2023\/01\/logo-dewpointx-color-square-1000x800-1.png","width":1000,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/dewpointx.com\/dewpoint-therapeutics-announces-upcoming-presentations-at-aacr-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dewpointx.com\/"},{"@type":"ListItem","position":2,"name":"Dewpoint Therapeutics Announces Upcoming Presentations at AACR 2025\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/dewpointx.com\/#website","url":"https:\/\/dewpointx.com\/","name":"Dewpoint Therapeutics","description":"The Biomolecular Condensates Company","publisher":{"@id":"https:\/\/dewpointx.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dewpointx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dewpointx.com\/#organization","name":"Dewpoint Therapeutics","url":"https:\/\/dewpointx.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dewpointx.com\/#\/schema\/logo\/image\/","url":"https:\/\/dewpointx.com\/wp-content\/uploads\/2022\/11\/favicon.png","contentUrl":"https:\/\/dewpointx.com\/wp-content\/uploads\/2022\/11\/favicon.png","width":512,"height":512,"caption":"Dewpoint Therapeutics"},"image":{"@id":"https:\/\/dewpointx.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/dewpoint_tx","https:\/\/www.linkedin.com\/company\/dewpointtherapeutics\/"]},{"@type":"Person","@id":"https:\/\/dewpointx.com\/#\/schema\/person\/1c488cd606671d5d3392602755639a0c","name":"Jennifer Tallman"}]}},"publishpress_future_action":{"enabled":false,"date":"2025-05-02 07:05:03","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/posts\/6731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/comments?post=6731"}],"version-history":[{"count":10,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/posts\/6731\/revisions"}],"predecessor-version":[{"id":6764,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/posts\/6731\/revisions\/6764"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/media\/3339"}],"wp:attachment":[{"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/media?parent=6731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/categories?post=6731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dewpointx.com\/wp-json\/wp\/v2\/tags?post=6731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}